Precious Ochuwa Imokhai

Ms. Precious Ochuwa Imokhai

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
HAHana Abbas
Hana Abbas
MTMaria Abou Taka
Maria Abou Taka
Precious Ochuwa ImokhaiPrecious Ochuwa Imokhai
Precious Ochuwa Imokhai
SSSatyam Kamla Singh
Satyam Kamla Singh
Christine GharibChristine Gharib
Christine Gharib
Amanda BrooksAmanda Brooks
Amanda Brooks
Background/Objectives: Radiomics-based machine learning models have demonstrated high accuracy in differentiating benign from malignant orbital masses, with early studies suggesting performance comparable to expert radiologists. However, translation into clinical practice remains limited due to dataset constraints, including retrospective study designs, single-center cohorts, and underrepresentation of diverse patient populations. This review aims to evaluate the current evidence supporting radiomics in orbital disease while critically examining barriers to generalizability and equity across ophthalmology, otolaryngology, and plastic surgery. Methods: A narrative literature review was conducted to assess radiomics applications in orbital oncology and reconstruction. Studies evaluating diagnostic accuracy, margin assessment, postoperative surveillance, and surgical planning across ophthalmology, head and neck surgery, and reconstructive surgery were analyzed, with particular attention paid to dataset composition, validation strategies, and imaging standardization. Results: Radiomics models demonstrated high diagnostic performance in differentiating orbital tumors, optimizing surgical planning, and aiding postoperative monitoring. However, most studies relied on small, homogeneous datasets lacking racial, ethnic, and pediatric representation. External validation was uncommon, and imaging heterogeneity limited reproducibility. These deficiencies restrict the clinical translation of radiomics and risk exacerbating healthcare disparities, particularly among underrepresented populations. Conclusions: Radiomics holds promise as a precision medicine tool for orbital diagnosis, surgical navigation, and postoperative care. Nevertheless, its clinical adoption is constrained by dataset bias, lack of standardization, and limited prospective validation. Future progress requires multi-institutional, demographically diverse datasets and standardized imaging protocols to ensure equitable and generalizable implementation across specialties.

25 October 2025 in International Journal of Research in Dermatology
Verified
Journal Article
Open access
PDF file
Precious Ochuwa ImokhaiPrecious Ochuwa Imokhai
Precious Ochuwa Imokhai
FMFalen Mehari
Falen Mehari
ZSZohair Sira
Zohair Sira
TVToan N. Vu
Toan N. Vu
JPJulie Paik
Julie Paik
KFKelly Frasier
Kelly Frasier
The rapid growth of aesthetic dermatology has amplified demand for hair removal among individuals with Fitzpatrick skin types IV-VI. However, traditional laser technologies, developed with lighter phototypes in mind, pose heightened risks of post inflammatory hyperpigmentation, scarring, and paradoxical hair growth in melanin-rich skin. This comprehensive review reconceptualizes the hair removal paradigm in skin of color (SOC) by integrating recent clinical data, histologic insights, and safety profiles across diverse technologies. Using dermal penetration models and comparative energy delivery diagrams, we demonstrate how long-pulsed Nd:YAG (1064 nm) lasers offer deeper follicular targeting with minimal epidermal melanin interaction, establishing them as the preferred modality in darker skin tones. We explore the emergence of melanin-independent radiofrequency (RF) and RF microneedling (RFM) systems, which generate controlled dermal heating without chromophore reliance, expanding their use in pseudofolliculitis barbae and scarring conditions. Topical alternatives like thioglycolates and eflornithine are re-evaluated for their synergistic potential in combination therapies, emphasizing safe regimens supported by evidence-based pre/post-treatment protocols. Importantly, this review addresses the critical gaps in dermatologic curricula, clinical trials, and device safety testing for SOC populations. Through an intersectional lens, we call for the development of Fitzpatrick-stratified laser protocols, standardization of treatment parameters, and inclusion of curl pattern morphology in care planning. By visualizing risk stratification trends, procedural pathways, and Melan in-histology interactions, this review offers a blueprint for delivering inclusive, precision-based cosmetic dermatology to historically underserved communities.

27 October 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JZJenny W. Zhang
Jenny W. Zhang
Precious Ochuwa ImokhaiPrecious Ochuwa Imokhai
Precious Ochuwa Imokhai
DLDanny Lee
Danny Lee
DHDiana Hamdan
Diana Hamdan
TMTrisha Mahajan
Trisha Mahajan
Amanda BrooksAmanda Brooks
Amanda Brooks
The medical condition of pregnancy-associated breast cancer (PABC) requires oncologists to determine the best way to protect both the mother and the fetus during cancer treatment. The safety profile of taxanes, including paclitaxel and docetaxel, in the second and third trimesters of pregnancy remains unclear despite well-established anthracycline-based regimens (e.g., doxorubicin). High-risk breast cancer subtypes such as triple negative breast cancer (TNBC) and human epidermal growth factor receptor (HER2)-positive disease require taxane chemotherapy as standard treatment in nonpregnant patients. Objective: This paper aims to gather available data about the safety, timing and fetal outcomes related to taxane chemotherapy during PABC, focusing on pharmacological and clinical guidance. Methods: A targeted literature review of PubMed and Scopus databases was performed to identify case series, cohort studies, and clinical guidelines addressing taxane use during pregnancy. This was not conducted as a formal systematic review or meta-analysis, but as a comprehensive narrative synthesis of available data. Results: The pharmacological properties of paclitaxel and docetaxel limit their placental transfer. Paclitaxel has not been associated with increased congenital anomalies; however, the long-term developmental data remain limited. Similarly, docetaxel administration shows no increase in major malformations. The most common approach used in PABC is to administer anthracyclines first and taxanes after 16–18 weeks’ gestation. The adverse effects experienced by pregnant patients match those experienced by nonpregnant patients. Conclusions: Taxanes can be used with caution after the first trimester in patients with PABC, especially in high-risk cases following anthracycline treatment. The absence of randomized trials combined with limited developmental data highlight the need for more standardized treatment approaches, aligning with current guideline recommendations.

1 January 2025 in ARC Journal of Dermatology
Verified
Journal Article
Closed access
Precious Ochuwa ImokhaiPrecious Ochuwa Imokhai
Precious Ochuwa Imokhai
RARenad Althobaiti
Renad Althobaiti
LJLilly Jimoh
Lilly Jimoh
SKSarah Kazemeini
Sarah Kazemeini
FMFalen Mehari
Falen Mehari
JVJulia Vinagolu-Baur
Julia Vinagolu-Baur

1 February 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DHDiana Hamdan
Diana Hamdan
Precious Ochuwa ImokhaiPrecious Ochuwa Imokhai
Precious Ochuwa Imokhai
AKAlexandra Konvalina
Alexandra Konvalina
BNBaoKhanh Nguyen
BaoKhanh Nguyen
MAMaha Alhoda
Maha Alhoda
Amanda BrooksAmanda Brooks
Amanda Brooks
Background: Neuroimaging protocols for neurotologic disease are often developed without consideration of patient-specific factors such as biological differences, clinical presentation variability, and comorbidities. This lack of tailored design contributes to insufficient detection, delayed diagnosis, and inappropriate treatment. Objectives: To critically examine the literature on diagnostic limitations of neuroimaging for neurotologic lesions and identify gaps in protocol validation, accuracy, and clinical translation. Methods: A systematic review of PubMed and Google Scholar was conducted, focusing on studies published between 2015 and 2025 that evaluated diagnostic imaging outcomes in patients with neurotologic lesions. Eligible studies included prospective cohorts, retrospective analyses, and consensus statements. Outcomes of interest included the sensitivity and specificity of imaging modalities, prevalence of misdiagnosis, and the influence of biological, anatomical, and clinical variability on diagnostic performance. Results: The literature demonstrates that neurotologic disorders are frequently associated with diagnostic challenges, including atypical clinical presentations, overlapping symptoms, and stroke mimics, which complicate image interpretation. Standard magnetic resonance imaging (MRI) protocols often miss subtle or early ischemic changes, resulting in delayed intervention. Few studies stratify outcomes by patient characteristics, and most protocols were developed in generalized populations without comprehensive validation. Evidence on advanced imaging modalities (positron emission tomography (PET), single-photon emission computed tomography (SPECT), high-resolution MRI) remains limited, and large-scale prospective studies addressing diagnostic accuracy gaps are lacking. In summary, a total of 27 studies met inclusion criteria. Conclusions: Current neuroimaging methods are insufficiently validated across diverse patient populations, contributing to the underdiagnosis and mismanagement of neurotologic disease. Improved diagnostic accuracy will require large-scale, prospective research, standardized outcome reporting, and imaging protocols designed to account for patient-specific variability.

6 May 2026 in Journal of Voice
Verified
Journal Article
Open access
KFKerol Faltas
Kerol Faltas
MFMarc Faltas
Marc Faltas
Precious Ochuwa ImokhaiPrecious Ochuwa Imokhai
Precious Ochuwa Imokhai
MTMaria Abou Taka
Maria Abou Taka
SAShivashri Anananthamurugan
Shivashri Anananthamurugan
Amanda BrooksAmanda Brooks
Amanda Brooks
Minimally invasive voice-preservation techniques, including microlaryngoscopy, phonosurgery, and office-based regenerative interventions, have revolutionized the management of benign and early-stage laryngeal disorders by minimizing fibrosis and preserving phonatory function. However, the long-term (>6 months) wound healing and extracellular matrix (ECM) remodeling dynamics that determine sustained vocal outcomes remain poorly understood, particularly among professional singers who experience high vibratory demand. Moreover, African American and minority singers continue to face significant barriers to specialty laryngology care, underrepresentation in research cohorts, and disparities in insurance coverage, creating inequities in both access and postoperative outcomes. This review synthesizes evidence on chronic wound healing and ECM remodeling following minimally invasive voice-preservation procedures, emphasizing histologic integration, molecular mediators of fibrosis, and correlations with objective (dysphonia severity index, vocal extent measure, and maximum phonation time) and subjective (voice handicap index, singing voice handicap index) recovery metrics. It also examines racial and socioeconomic inequities in laryngeal care among professional voice users. Our method for this research was to use PubMed, JStor, Web of Science, and Cochrane Library databases starting from 2000. The study will include randomized controlled trials and observational cohorts and case series with ten or more patients and previous systematic reviews that focus on wound healing and functional outcomes and access disparities. Two reviewers will conduct independent screening and data extraction, while thematic synthesis will be used to organize existing evidence and identify areas where more research is needed. Existing studies demonstrate consistent short-term improvement in acoustic and perceptual metrics but limited histologic data beyond 9-12 months. Available human biopsy findings reveal fibroblast infiltration and partial ECM integration (eg, silk-hyaluronic acid hydrogels, adipose-derived stromal vascular fraction therapy), yet lack quantitative analysis of collagen I/III ratios, elastin content, and viscoelastic restoration. Professional singers remain largely excluded from histologic or biomechanical cohorts. Persistent racial and geographic disparities further limit access to specialized voice-preservation surgery and longitudinal follow-up. Long-term remodeling after minimally invasive voice-preservation procedures remains underexplored, with crucial gaps in linking tissue biomechanics to clinical outcomes and health equity. This review identifies priorities for multicenter, demographically inclusive research integrating molecular, histologic, and performance-based endpoints to advance equitable, evidence-based voice care for professional singers and high-demand voice users.